Literature DB >> 11320325

Crystallization and preliminary X-ray diffraction studies of the epsilonzeta addiction system encoded by Streptococcus pyogenes plasmid pSM19035.

A Meinhart1, C Alings, N Sträter, A G Camacho, J C Alonso, W Saenger.   

Abstract

The proteins encoded by the Streptococcus pyogenes broad-host range and low copy-number plasmid pSM19035 form a toxin-antitoxin module that secures stable maintenance by causing the death of plasmid-free segregants. The epsilonzeta protein complex was crystallized in four different forms at pH 5.0 and pH 7.0 using the vapour-diffusion method with PEG 3350 and ethylene glycol as precipitants. Three of the crystal forms were obtained in the same droplet under identical conditions at pH 5.0. One form belongs to the enantiomorphic space groups P4(3)2(1)2 or P4(1)2(1)2. For the other two, the X-ray reflection conditions match those of space group P2(1)2(1)2(1), one representing a superlattice of the other. A crystal form growing at pH 7.0 also belongs to space group P2(1)2(1)2(1), but there is no indication of a structural relationship to the other orthorhombic forms. Initially, the crystals diffracted to 2.9 A resolution and diffracted to 1.95 A after soaking at pH 7.0. A preparation of selenomethionyl epsilonzeta protein complex yielded single crystals suitable for X-ray diffraction experiments using synchrotron sources.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320325     DOI: 10.1107/s0907444901004176

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  10 in total

1.  Crystal structure of the plasmid maintenance system epsilon/zeta: functional mechanism of toxin zeta and inactivation by epsilon 2 zeta 2 complex formation.

Authors:  Anton Meinhart; Juan C Alonso; Norbert Sträter; Wolfram Saenger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

2.  Modular organization of the Phd repressor/antitoxin protein.

Authors:  Jeremy Allen Smith; Roy David Magnuson
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

Review 3.  ε/ζ systems: their role in resistance, virulence, and their potential for antibiotic development.

Authors:  Hannes Mutschler; Anton Meinhart
Journal:  J Mol Med (Berl)       Date:  2011-08-06       Impact factor: 4.599

4.  The ζ toxin induces a set of protective responses and dormancy.

Authors:  Virginia S Lioy; Cristina Machon; Mariangela Tabone; José E Gonzalez-Pastor; Rimantas Daugelavicius; Silvia Ayora; Juan C Alonso
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

5.  Role of toxin ζ and starvation responses in the sensitivity to antimicrobials.

Authors:  Mariangela Tabone; Virginia S Lioy; Silvia Ayora; Cristina Machón; Juan C Alonso
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

6.  Toxin ζ reversible induces dormancy and reduces the UDP-N-acetylglucosamine pool as one of the protective responses to cope with stress.

Authors:  Mariangela Tabone; Silvia Ayora; Juan C Alonso
Journal:  Toxins (Basel)       Date:  2014-09-18       Impact factor: 4.546

7.  Toxin ζ Triggers a Survival Response to Cope with Stress and Persistence.

Authors:  María Moreno-Del Álamo; Mariangela Tabone; Virginia S Lioy; Juan C Alonso
Journal:  Front Microbiol       Date:  2017-06-23       Impact factor: 5.640

8.  Toxin ζ Reduces the ATP and Modulates the Uridine Diphosphate-N-acetylglucosamine Pool.

Authors:  María Moreno-Del Álamo; Mariangela Tabone; Juan Muñoz-Martínez; José R Valverde; Juan C Alonso
Journal:  Toxins (Basel)       Date:  2019-01-09       Impact factor: 4.546

9.  Antitoxin ε Reverses Toxin ζ-Facilitated Ampicillin Dormants.

Authors:  María Moreno-Del Álamo; Chiara Marchisone; Juan C Alonso
Journal:  Toxins (Basel)       Date:  2020-12-15       Impact factor: 4.546

Review 10.  Bacterial toxin-antitoxin systems: more than selfish entities?

Authors:  Laurence Van Melderen; Manuel Saavedra De Bast
Journal:  PLoS Genet       Date:  2009-03-27       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.